Showing results (31-40 of 79) with videos related to
Sort By:
Pageof 8
Hemasphere|December 3, 2024
Cerebral hemodynamics and oxygen metabolism in patients with milder and severe forms of sickle cell disease and thalassemiaLiza Afzali-Hashemi, Koen P A Baas, Anouk Schrantee, et al.American Journal of Hematology|January 6, 2026
Effect of Red Blood Cell Transfusion on Inflammatory and Angiogenic Pathways in Patients With Sickle Cell DiseaseLydian A de Ligt, Sanjay R Thakoerdin, Maud Zwolsman, et al.Biochimica Et Biophysica Acta|May 12, 2011
Increased efflux of oxidized glutathione (GSSG) causes glutathione depletion and potentially diminishes antioxidant defense in sickle erythrocytesErfan Nur, Mirjam Verwijs, Dirk R de Waart, et al.European Journal of Haematology|August 15, 2019
Survival of early posthematopoietic stem cell transplantation relapse of myeloid malignanciesGreta de Jong, Jeroen J W M Janssen, Bart J Biemond, et al.The Journal of Clinical Endocrinology and Metabolism|May 21, 2009
Hypercoagulable state in Cushing's syndrome: a systematic reviewBregje Van Zaane, Erfan Nur, Alessandro Squizzato, et al.Transplantation and Cellular Therapy|January 12, 2023
Physical, Mental, and Social Health of Adult Patients with Sickle Cell Disease after Allogeneic Hematopoietic Stem Cell Transplantation: A Mixed-Methods StudyElisabeth Dovern, Sterre J A M Nijland, Maud M van Muilekom, et al.Annals of Clinical Biochemistry|October 27, 2025
Elevated haemoglobin A1c confounds thalassaemia diagnosis by lowering HbA2 levelsJeroen Slaats, Erfan Nur, Harriët Heijboer, et al.European Journal of Haematology|June 5, 2023
A multimodal pain protocol for treatment of vaso-occlusive crisis in patients with sickle cell disease: Implementation and evaluationManouk Admiraal, Jonathan van Daalen, Michael W J Ritt, et al.Frontiers in Immunology|May 19, 2025
Dynamics of neutrophil phenotype and function in sickle cell diseaseAafke E Gaartman, Lydian A de Ligt, Boukje M Beuger, et al.British Journal of Haematology|July 15, 2021
Fluid overload due to intravenous fluid therapy for vaso-occlusive crisis in sickle cell disease: incidence and risk factorsAafke E Gaartman, Ajab K Sayedi, Jorn J Gerritsma, et al.Pageof 8